Lomustine in Addition to Standard of Care in Patients With MGMT Methylated Glioblastoma

NCT06419946 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

200

Enrollment

OTHER_GOV

Sponsor class

Conditions

Glioblastoma, IDH-wildtype
MGMT-Methylated Glioblastoma

Interventions

DRUG: Temozolomide
DRUG: Lomustine

Sponsor

Vastra Gotaland Region

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]